1. Field of the Invention
The present invention relates to methods and devices for reinforcing dysfunctional heart valves and other body structures. More specifically, the present invention relates to annuloplasty rings that can be adjusted within the body of a patient.
2. Description of the Related Art
The circulatory system of mammals includes the heart and the interconnecting vessels throughout the body that include both veins and arteries. The human heart includes four chambers, which are the left and right atrium and the left and right ventricles. The mitral valve, which allows blood flow in one direction, is positioned between the left ventricle and left atrium. The tricuspid valve is positioned between the right ventricle and the right atrium. The aortic valve is positioned between the left ventricle and the aorta, and the pulmonary valve is positioned between the right ventricle and pulmonary artery. The heart valves function in concert to move blood throughout the circulatory system. The right ventricle pumps oxygen-poor blood from the body to the lungs and then into the left atrium. From the left atrium, the blood is pumped into the left ventricle and then out the aortic valve into the aorta. The blood is then recirculated throughout the tissues and organs of the body and returns once again to the right atrium.
If the valves of the heart do not function properly, due either to disease or congenital defects, the circulation of the blood may be compromised. Diseased heart valves may be stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely. Incompetent heart valves cause regurgitation or excessive backward flow of blood through the valve when the valve is closed. For example, certain diseases of the heart valves can result in dilation of the heart and one or more heart valves. When a heart valve annulus dilates, the valve leaflet geometry deforms and causes ineffective closure of the valve leaflets. The ineffective closure of the valve can cause regurgitation of the blood, accumulation of blood in the heart, and other problems.
Diseased or damaged heart valves can be treated by valve replacement surgery, in which damaged leaflets are excised and the annulus is sculpted to receive a replacement valve. Another repair technique that has been shown to be effective in treating incompetence is annuloplasty, in which the effective size of the valve annulus is contracted by attaching a prosthetic annuloplasty repair segment or ring to an interior wall of the heart around the valve annulus. The annuloplasty ring reinforces the functional changes that occur during the cardiac cycle to improve coaptation and valve integrity. Thus, annuloplasty rings help reduce reverse flow or regurgitation while permitting good hemodynamics during forward flow.
Generally, annuloplasty rings comprise an inner substrate of a metal such as stainless steel or titanium, or a flexible material such as silicon rubber or Dacron®. The inner substrate is generally covered with a biocompatible fabric or cloth to allow the ring to be sutured to the heart tissue. Annuloplasty rings may be stiff or flexible, may be open or closed, and may have a variety of shapes including circular, D-shaped, or C-shaped. The configuration of the ring is generally based on the shape of the heart valve being repaired or on the particular application. For example, the tricuspid valve is generally circular and the mitral valve is generally D-shaped. Further, C-shaped rings may be used for tricuspid valve repairs, for example, because it allows a surgeon to position the break in the ring adjacent the atrioventricular node, thus avoiding the need for suturing at that location.
Annuloplasty rings support the heart valve annulus and restore the valve geometry and function. Although the implantation of an annuloplasty ring can be effective, the heart of a patient may change geometry over time after implantation. For example, the heart of a child will grow as the child ages. As another example, after implantation of an annuloplasty ring, dilation of the heart caused by accumulation of blood may cease and the heart may begin returning to its normal size. Whether the size of the heart grows or reduces after implantation of an annuloplasty ring, the ring may no longer be the appropriate size for the changed size of the valve annulus.
Thus, it would be advantageous to develop systems and methods for reinforcing a heart valve annulus or other body structure using an annuloplasty device that can be adjusted within the body of a patient in a minimally invasive or non-invasive manner.
In one embodiment, an adjustable annuloplasty device is disclosed. The device comprises a body member comprising a shape memory material, the body member configured to be placed at or near a base of a valve of a heart. The device further comprises a hysteretic material configured to undergo magnetic hysteresis in response to a first activation energy, the hysteretic material being in thermal communication with the shape memory material. The body member may have a first size of a body member dimension in a first configuration and a second size of the body member dimension in a second configuration. When the body member is in position in the heart, a change from the first configuration to the second configuration changes a size of a dimension of the annulus of the valve.
In certain embodiments, the change from the first configuration to the second configuration occurs in response to heating of the shape memory material. In certain embodiments of the device, the first activation energy comprises a magnetic field. In certain embodiments of the device, the magnetic field comprises a time varying magnetic field. In certain embodiments of the device, the hysteretic material coats the body member. In certain embodiments of the device, the coat has a thickness between about 10 microns to about 1 centimeter. In certain embodiments of the device, the hysteretic material is alloyed with the shape memory material. In certain embodiments of the device, the hysteretic material is further configured to heat in response to the first activation energy. In certain embodiments of the device, the heat is due to electromagnetic induction heating. In certain embodiments of the device, the hysteretic material is configured to transfer heat to the shape memory material. In certain embodiments of the device, the shape memory material comprises at least one of a metal, a metal alloy, a nickel titanium alloy, a shape memory polymer, polylactic acid, and polyglycolic acid. In certain embodiments of the device, the hysteretic material comprises a ferromagnetic material. Certain embodiments of the device further comprise a suturable material configured to facilitate attachment of the body member to the cardiac valve annulus. In certain embodiments of the device, the body member has a third size of the body member dimension in a third configuration, wherein the third size is larger than the second size, and wherein the body member is configured to transform to the third configuration in response to a second activation energy to increase the dimension of the cardiac valve annulus. In certain embodiments of the device, the body member has a third size of the body member dimension in a third configuration, wherein the third size is smaller than the second size, and wherein the body member is configured to transform to the third configuration in response to a second activation energy to decrease the dimension of the cardiac valve annulus. In certain embodiments of the device, the hysteretic material comprises a nanoparticle. The nanoparticle may comprise at least one of a nanoshell and a nanosphere. In certain embodiments of the device, the hysteretic material is radiopaque. In certain embodiments of the device, the hysteretic material is ferromagnetic. In certain embodiments of the device, the hysteretic material has a Curie point in the range of 40 to 70 degrees Celsius. In certain embodiments of the device, the hysteretic material has a Curie point in the range of 45 to 55 degrees Celsius.
In one embodiment, a method for adjusting the shape of an implant is disclosed. The method comprises providing an adjustable annuloplasty device, comprising a body member comprising a shape memory material, the body member configured to be placed at or near a base of a valve of a heart; a hysteretic material configured to undergo magnetic hysteresis in response to a first activation energy from a magnetic field, the hysteretic material being in thermal communication with the shape memory material; wherein the body member has a first size of a body member dimension in a first configuration and a second size of the body member dimension in a second configuration; and wherein, when the body member is in position in the heart, a change in the body member from the first configuration to the second configuration changes a size of a dimension of the annulus of the valve. The method further comprises exposing the device to the magnetic field, changing the body member from the first configuration to the second configuration.
In certain embodiments, the change from the first configuration to the second configuration occurs in response to heating of the shape memory material. In certain embodiments, the magnetic field comprises a time varying magnetic field. In certain embodiments of the method, the magnetic field is produced by an electromagnet driven with an alternating current. In certain embodiments of the method, the alternating current is in the range of 0.001 Hz to 1000 MHz. In certain embodiments of the method, alternating current is in the range of 10 Hz to 100 KHz. In certain embodiments of the method, the alternating current is in the range of 15 KHz to 25 KHz. In certain embodiments of the method, the magnetic field is produced by an electromagnet driven with a modulated alternating current. In certain embodiments of the method, the modulated alternating current comprises amplitude modulation. In certain embodiments of the method, the modulated alternating current comprises frequency modulation. In certain embodiments of the method, the modulated alternating current comprises phase modulation. In certain embodiments of the method, the magnetic field is produced by a plurality of electromagnets driven with a modulated alternating current source with controlled phase relationships. In certain embodiments of the method, the magnetic field is produced by a permanent magnet that is mechanically displaced back and forth by a mechanical driver. In certain embodiments of the method, the mechanical displacement is oscillatory. In certain embodiments of the method, the mechanical displacement is a resonant motion. In certain embodiments of the method, the magnetic field is produced by an electromagnet that is mechanically displaced. In certain embodiments of the method, the electromagnet is driven by a DC current. In certain embodiments of the method, the mechanical displacement is oscillatory. In certain embodiments of the method, the mechanical displacement is a resonant motion. In certain embodiments of the method, the electromagnet is driven by an AC current. In certain embodiments of the method, the magnetic field is produced by imposing at least one high frequency magnetic field on at least one low frequency magnetic field. Certain embodiments of the method further comprise a feedback system configured to provide regulation and control of at least one of the magnetic field intensity or the method temperature.
In one embodiment, an annuloplasty system is disclosed. The system comprises an adjustable annuloplasty device, comprising a body member comprising a shape memory material, the body member configured to be placed at or near a base of a valve of a heart; a hysteretic material configured to undergo magnetic hysteresis in response to a first activation energy from a magnetic field, the hysteretic material being in thermal communication with the shape memory material; wherein the body member has a first size of a body member dimension in a first configuration and a second size of the body member dimension in a second configuration; and wherein, when the body member is in position in the heart, a change in the body member from the first configuration to the second configuration changes a size of a dimension of the annulus of the valve. The system further comprises a magnet, configured to emanate the magnetic field.
In certain embodiments, the change from the first configuration to the second configuration occurs in response to heating of the shape memory material. In certain embodiments of the system, the magnetic field is produced by an electromagnet driven with an alternating current. In certain embodiments of the system, the alternating current is in the range of 0.001 Hz to 1000 MHz. In certain embodiments of the system, alternating current is in the range of 10 Hz to 100 KHz. In certain embodiments of the system, the alternating current is in the range of 15 KHz to 25 KHz. In certain embodiments of the system, the magnetic field is produced by an electromagnet driven with a modulated alternating current. In certain embodiments of the system, the modulated alternating current comprises amplitude modulation. In certain embodiments of the system, the modulated alternating current comprises frequency modulation. In certain embodiments of the system, the modulated alternating current comprises phase modulation. In certain embodiments of the system, the magnetic field is produced by a plurality of electromagnets driven with a modulated alternating current source with controlled phase relationships. In certain embodiments of the system, the magnetic field is produced by a permanent magnet that is mechanically displaced back and forth by a mechanical driver. In certain embodiments of the system, the mechanical displacement is oscillatory. In certain embodiments of the system, the mechanical displacement is a resonant motion. In certain embodiments of the system, the magnetic field is produced by an electromagnet that is mechanically displaced. In certain embodiments of the system, the electromagnet is driven by a DC current. In certain embodiments of the system, the mechanical displacement is oscillatory. In certain embodiments of the system, the mechanical displacement is a resonant motion. In certain embodiments of the system, the electromagnet is driven by an AC current. In certain embodiments of the system, the magnetic field is produced by imposing at least one high frequency magnetic field on at least one low frequency magnetic field. Certain embodiments of the system further comprise a feedback system configured to provide regulation and control of at least one of the magnetic field intensity or the system temperature.
In one embodiment, an adjustable annuloplasty device is disclosed. The device comprises means for supporting a heart valve comprising a shape memory material, the means for supporting being configured to be placed at or near a base of a valve of a heart. The device further comprises means for undergoing magnetic hysteresis in response to a first activation energy, the means for undergoing magnetic hysteresis being in thermal communication with the shape memory material. The means for supporting has a first size of a body member dimension in a first configuration and a second size of the body member dimension in a second configuration. When the means for supporting is in position in the heart, a change from the first configuration to the second configuration changes a size of a dimension of the annulus of the valve.
For purposes of summarizing the invention, certain aspects, advantages, and novel features of the invention have been described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment of the invention. Thus, the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
A general architecture that implements the various features of the invention will now be described with reference to the drawings, The drawings and the associated descriptions are provided to illustrate embodiments of the invention and not to limit the scope of the invention. Throughout the drawings, reference numbers are re-used to indicate correspondence between referenced elements.
The invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is therefore indicated by the appended claims rather than the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
The present invention involves systems and methods for reinforcing dysfunctional heart valves and other body structures with adjustable rings. In certain embodiments, an adjustable annuloplasty ring is implanted into the body of a patient such as a human or other animal. The adjustable annuloplasty ring is implanted through an incision or body opening either thoracically (e.g., open-heart surgery) or percutaneously (e.g., via a femoral artery or vein, or other arteries or veins) as is known to someone skilled in the art. The adjustable annuloplasty ring is attached to the annulus of a heart valve to improve leaflet coaptation and to reduce regurgitation. The annuloplasty ring may be selected from one or more shapes comprising a round or circular shape, an oval shape, a C-shape, a D-shape, a U-shape, an open circle shape, an open oval shape, and other curvilinear shapes.
The size of the annuloplasty ring can be adjusted postoperatively to compensate for changes in the size of the heart. As used herein, the term “postoperatively” refers to a time after implanting the adjustable annuloplasty ring and closing the body opening through which the adjustable annuloplasty ring was introduced into the patient's body. For example, the annuloplasty ring may be implanted in a child whose heart grows as the child gets older. Thus, the size of the annuloplasty ring may need to be increased. As another example, the size of an enlarged heart may start to return to its normal size after an annuloplasty ring is implanted. Thus, the size of the annuloplasty ring may need to be decreased postoperatively to continue to reinforce the heart valve annulus.
In certain embodiments, the annuloplasty ring comprises a shape memory material that is responsive to -changes in temperature and/or exposure to a magnetic field. Shape memory is the ability of a material to regain its shape after deformation. Shape memory materials include polymers, metals, metal alloys and ferromagnetic alloys. The annuloplasty ring is adjusted in vivo by applying an energy source to activate the shape memory material and cause it to change to a memorized shape. The energy source may include, for example, thermal energy, radio frequency (RF) energy, x-ray energy, microwave energy, ultrasonic energy such as focused ultrasound, high intensity focused ultrasound (HIFU) energy, light energy, electric field energy, magnetic field energy, combinations of the foregoing, or the like. For example, one embodiment of electromagnetic radiation that is useful is infrared energy having a wavelength in a range between approximately 750 nanometers and approximately 1600 nanometers. This type of infrared radiation may be produced efficiently by a solid state diode laser. In certain embodiments, the annuloplasty ring implant is selectively heated using short pulses of energy having an on and off period between each cycle. The energy pulses provide segmental heating which allows segmental adjustment of portions of the annuloplasty ring without adjusting the entire implant.
In certain embodiments, the annuloplasty ring includes an energy absorbing material to increase heating efficiency and localize heating in the area of the shape memory material. Thus, damage to the surrounding tissue is reduced or minimized. Energy absorbing materials for light or laser activation energy may include nanoshells, nanospheres and the like, particularly where infrared laser energy is used to energize the material. Such nanoparticles may be made from a dielectric, such as silica, coated with an ultra thin layer of a conductor, such as gold, and be selectively tuned to absorb a particular frequency of electromagnetic radiation. In certain such embodiments, the nanoparticles range in size between about 5 nanometers and about 20 nanometers and can be suspended in a suitable material or solution, such as saline solution. In certain embodiments, the nanoparticles range in size between about 2 nanometers and about 30 nanometers. In certain embodiments, the nanoparticles range in size between about 5 nanometers and about 20 nanometers. In certain embodiments, the nanoparticles range in size between about 8 nanometers and about 15 nanometers. Coatings comprising nanotubes or nanoparticles can also be used to absorb energy from, for example, HIFU, MRI, inductive heating, or the like.
In other embodiments, thin film deposition or other coating techniques such as sputtering, reactive sputtering, metal ion implantation, physical vapor deposition, and chemical deposition can be used to cover portions or all of the annuloplasty ring. Such coatings can be either solid or microporous. When HIFU energy is used, for example, a microporous structure traps and directs the HIFU energy toward the shape memory material. The coating improves thermal conduction and heat removal. In certain embodiments, the coating also enhances radio-opacity of the annuloplasty ring implant. Coating materials can be selected from various groups of biocompatible organic or non-organic, metallic or non-metallic materials such as Titanium Nitride (TiN), Iridium Oxide (Irox), Carbon, Platinum black, Titanium Carbide (TiC) and other materials used for pacemaker electrodes or implantable pacemaker leads. Other materials discussed herein or known in the art can also be used to absorb energy.
In addition, or in other embodiments, fine conductive wires such as platinum coated copper, titanium, tantalum, stainless steel, gold, or the like, are wrapped around the shape memory material to allow focused and rapid heating of the shape memory material while reducing undesired heating of surrounding tissues.
In certain embodiments, the energy source is applied surgically either during implantation or at a later time. For example, the shape memory material can be heated during implantation of the annuloplasty ring by touching the annuloplasty ring with warm object. As another example, the energy source can be surgically applied after the annuloplasty ring has been implanted by percutaneously inserting a catheter into the patient's body and applying the energy through the catheter. For example, RF energy, light energy or thermal energy (e.g., from a heating element using resistance heating) can be transferred to the shape memory material through a catheter positioned on or near the shape memory material. Alternatively, thermal energy can be provided to the shape memory material by injecting a heated fluid through a catheter or circulating the heated fluid in a balloon through the catheter placed in close proximity to the shape memory material. As another example, the shape memory material can be coated with a photodynamic absorbing material which is activated to heat the shape memory material when illuminated by light from a laser diode or directed to the coating through fiber optic elements in a catheter. In certain such embodiments, the photodynamic absorbing material includes one or more drugs that are released when illuminated by the laser light.
In certain embodiments, a removable subcutaneous electrode or coil couples energy from a dedicated activation unit. In certain embodiments, an electromagnetic coil is used. In certain embodiments, a removable subcutaneous electrode provides telemetry and power transmission between the system and the annuloplasty ring. The subcutaneous removable electrode allows more efficient coupling of energy to the implant with minimum or reduced power loss. In certain embodiments, the subcutaneous energy is delivered via inductive coupling.
In certain embodiments, the catheter may be guided to or coupled with the implant with the assistance of external means. In certain embodiments, the catheter can have additional sensors or electrodes to detect physiological or hemodynamic parameters. For example, the catheter may be capable of detecting pressure, temperature, ECG, and oxygen saturation. In certain embodiments, the catheter may comprise imaging capabilities. For example, a catheter capable of ultrasound imaging may have a built-in ultrasound transducer and may be linked with ultrasound imaging equipment. Such a catheter may allow simultaneous therapy and imaging.
In other embodiments, the energy source is applied in a non-invasive manner from outside the patient's body. In certain such embodiments, the external energy source is focused to provide directional heating to the shape memory material so as to reduce or minimize damage to the surrounding tissue. For example, in certain embodiments, a handheld or portable device comprising an electrically conductive coil generates an electromagnetic field that non-invasively penetrates the patient's body and induces a current in the annuloplasty ring. The current heats the annuloplasty ring and causes the shape memory material to transform to a memorized shape. In certain such embodiments, the annuloplasty ring also comprises an electrically conductive coil wrapped around or embedded in the memory shape material. The externally generated electromagnetic field induces a current in the annuloplasty ring's coil, causing it to heat and transfer thermal energy to the shape memory material. In certain other embodiments, the annuloplasty ring includes a coating, powder, slurry, paste, or combination of the foregoing, that absorbs energy from the electromagnetic field and transforms the energy into heat to change the temperature of the shape memory material, as discussed below. Such coatings may include, for example, a wide variety of magnetic and non-magnetic mixtures.
The term “magnetic” as used herein is a broad term and is used in its ordinary sense and includes, without limitation, any material that easily magnetizes, such as a material having atoms that orient their electron spins to conform to an external magnetic field. A magnetic coating may comprise materials exhibiting magnetic behavior or that may be magnetized by another magnet, including, but not limited to, ferromagnetism (including ferrimagnetism), diamagnetism and paramagnetism.
In certain other embodiments, an external HIFU transducer focuses ultrasound energy onto the implanted annuloplasty ring to heat the shape memory material. In certain such embodiments, the external HIFU transducer is a handheld or portable device. The terms “HIFU,” “high intensity focused ultrasound” or “focused ultrasound” as used herein are broad terms and are used at least in their ordinary sense and include, without limitation, acoustic energy within a wide range of intensities and/or frequencies. For example, HIFU includes acoustic energy focused in a region, or focal zone, having an intensity and/or frequency that is considerably less than what is currently used for ablation in medical procedures. Thus, in certain such embodiments, the focused ultrasound is not destructive to the patient's cardiac tissue. In certain embodiments, HIFU includes acoustic energy within a frequency range of approximately 0.5 MHz and approximately 30 MHz and a power density within a range of approximately 1 W/cm2 and approximately 500 W/cm2.
In certain embodiments, the annuloplasty ring comprises an ultrasound absorbing material or hydro-gel material that allows focused and rapid heating when exposed to the ultrasound energy and transfers thermal energy to the shape memory material. In certain embodiments, a HIFU probe is used with an adaptive lens to compensate for heart and respiration movement. The adaptive lens has multiple focal point adjustments. In certain embodiments, a HIFU probe with adaptive capabilities comprises a phased array or linear configuration. In certain embodiments, an external HIFU probe comprises a lens configured to be placed between a patient's ribs to improve acoustic window penetration and reduce or minimize issues and challenges regarding passing through bones. In certain embodiments, HIFU energy is synchronized with an ultrasound imaging device to allow visualization of the annuloplasty ring implant during HIFU activation. In addition, or in other embodiments, ultrasound imaging is used to non-invasively monitor the temperature of tissue surrounding the annuloplasty ring by using principles of speed of sound shift and changes to tissue thermal expansion.
In certain embodiments, non-invasive energy is applied to the implanted annuloplasty ring using a Magnetic Resonance Imaging (MRI) device. In certain such embodiments, the shape memory material is activated by a constant magnetic field generated by the MRI device. In addition, or in other embodiments, the MRI device generates RF pulses that induce current in the annuloplasty ring and heat the shape memory material. The annuloplasty ring can include one or more coils and/or MRI energy absorbing material to increase the efficiency and directionality of the heating. Suitable energy absorbing materials for magnetic activation energy include particulates of ferromagnetic material. Suitable energy absorbing materials for RF energy include ferrite materials as well as other materials configured to absorb RF energy at resonant frequencies thereof.
In certain embodiments, the MRI device is used to determine the size of the implanted annuloplasty ring before, during and/or after the shape memory material is activated. In certain such embodiments, the MRI device generates RF pulses at a first frequency to heat the shape memory material and at a second frequency to image the implanted annuloplasty ring. Thus, the size of the annuloplasty ring can be measured without heating the ring. In certain such embodiments, an MRI energy absorbing material heats sufficiently to activate the shape memory material when exposed to the first frequency and does not substantially heat when exposed to the second frequency. Other imaging techniques known in the art can also be used to determine the size of the implanted ring including, for example, ultrasound imaging, computed tomography (CT) scanning, X-ray imaging, or the like. In certain embodiments, such imaging techniques also provide sufficient energy to activate the shape memory material.
In certain embodiments, imaging and resizing of the annuloplasty ring is performed as a separate procedure at some point after the annuloplasty ring as been surgically implanted into the patient's heart and the patient's heart, pericardium and chest have been surgically closed. However, in certain other embodiments, it is advantageous to perform the imaging after the heart and/or pericardium have been closed, but before closing the patient's chest, to check for leakage or the amount of regurgitation. If the amount of regurgitation remains excessive after the annuloplasty ring has been implanted, energy from the imaging device (or from another source as discussed herein) can be applied to the shape memory material so as to at least partially contract the annuloplasty ring and reduce regurgitation to an acceptable level. Thus, the success of the surgery can be checked and corrections can be made, if necessary, before closing the patient's chest.
In certain embodiments, activation of the shape memory material is synchronized with the heart beat during an imaging procedure. For example, an imaging technique can be used to focus HIFU energy onto an annuloplasty ring in a patient's body during a portion of the cardiac cycle. As the heart beats, the annuloplasty ring may move in and out of this area of focused energy. To reduce damage to the surrounding tissue, the patient's body is exposed to the HIFU energy only during portions of the cardiac cycle that focus the HIFU energy onto the cardiac ring. In certain embodiments, the energy is gated with a signal that represents the cardiac cycle such as an electrocardiogram signal. In certain such embodiments, the synchronization and gating is configured to allow delivery of energy to the shape memory materials at specific times during the cardiac cycle to avoid or reduce the likelihood of causing arrhythmia or fibrillation during vulnerable periods. For example, the energy can be gated so as to only expose the patient's heart to the energy during the T wave of the electrocardiogram signal.
As discussed above, shape memory materials include, for example, polymers, metals, and metal alloys including ferromagnetic alloys. Exemplary shape memory polymers that are usable for certain embodiments of the present invention are disclosed by Langer, et al. In U.S. Pat. No. 6,720,402, issued Apr. 13, 2004, U.S. Pat. No. 6,388,043, issued May 14, 2002, and 6,160,084, issued Dec. 12, 2000, each of which are hereby incorporated by reference herein. Shape memory polymers respond to changes in temperature by changing to one or more permanent or memorized shapes. In certain embodiments, the shape memory polymer is heated to a temperature between approximately 38 degrees Celsius and approximately 60 degrees Celsius. In certain other embodiments, the shape memory polymer is heated to a temperature in a range between approximately 40 degrees Celsius and approximately 55 degrees Celsius. In certain embodiments, the shape memory polymer has a two-way shape memory effect wherein the shape memory polymer is heated to change it to a first memorized shape and cooled to change it to a second memorized shape. The shape memory polymer can be cooled, for example, by inserting or circulating a cooled fluid through a catheter.
Shape memory polymers implanted in a patient's body can be heated non-invasively using, for example, external light energy sources such as infrared, near-infrared, ultraviolet, microwave and/or visible light sources. Preferably, the light energy is selected to increase absorption by the shape memory polymer and reduce absorption by the surrounding tissue. Thus, damage to the tissue surrounding the shape memory polymer is reduced when the shape memory polymer is heated to change its shape. In other embodiments, the shape memory polymer comprises gas bubbles or bubble containing liquids such as fluorocarbons and is heated by inducing a cavitation effect in the gas/liquid when exposed to HIFU energy. In other embodiments, the shape memory polymer may be heated using electromagnetic fields and may be coated with a material that absorbs electromagnetic fields.
Certain metal alloys have shape memory qualities and respond to changes in temperature and/or exposure to magnetic fields. Exemplary shape memory alloys that respond to changes in temperature include titanium-nickel, copper-zinc-aluminum, copper-aluminum-nickel, iron-manganese-silicon, iron-nickel-aluminum, gold-cadmium, combinations of the foregoing, and the like. In certain embodiments, the shape memory alloy comprises a biocompatible material such as a titanium-nickel alloy.
Shape memory alloys exist in two distinct solid phases called martensite and austenite. The martensite phase is relatively soft and easily deformed, whereas the austenite phase is relatively stronger and less easily deformed. For example, shape memory alloys enter the austenite phase at a relatively high temperature and the martensite phase at a relatively low temperature. Shape memory alloys begin transforming to the martensite phase at a start temperature (Ms) and finish transforming to the martensite phase at a finish temperature (Mf). Similarly, such shape memory alloys begin transforming to the austenite phase at a start temperature (As) and finish transforming to the austenite phase at a finish temperature (Af). Both transformations have a hysteresis. Thus, the Ms temperature and the Af temperature are not coincident with each other, and the Mf temperature and the As temperature are not coincident with each other.
In certain embodiments, the shape memory alloy is processed to form a memorized shape in the austenite phase in the form of a ring or partial ring. The shape memory alloy is then cooled below the Mf temperature to enter the martensite phase and deformed into a larger or smaller ring. For example, in certain embodiments, the shape memory alloy is formed into a ring or partial ring that is larger than the memorized shape but still small enough to improve leaflet coaptation and reduce regurgitation in a heart valve upon being attached to the heart valve annulus. In certain such embodiments, the shape memory alloy is sufficiently malleable in the martensite phase to allow a user such as a physician to adjust the circumference of the ring in the martensite phase by hand to achieve a desired fit for a particular heart valve annulus. After the ring is attached to the heart valve annulus, the circumference of the ring can be adjusted non-invasively by heating the shape memory alloy to an activation temperature (e.g., temperatures ranging from the As temperature to the Af temperature).
Thereafter, when the shape memory alloy is exposed to a temperature elevation and transformed to the austenite phase, the alloy changes in shape from the deformed shape to the memorized shape. Activation temperatures at which the shape memory alloy causes the shape of the annuloplasty ring to change shape can be selected and built into the annuloplasty ring such that collateral damage is reduced or eliminated in tissue adjacent the annuloplasty ring during the activation process. Exemplary Af temperatures for suitable shape memory alloys range between approximately 45 degrees Celsius and approximately 70 degrees Celsius. Furthermore, exemplary Ms temperatures range between approximately 10 degrees Celsius and approximately 20 degrees Celsius, and exemplary Mf temperatures range between approximately −1 degrees Celsius and approximately 15 degrees Celsius. The size of the annuloplasty ring can be changed all at once or incrementally in small steps at different times in order to achieve the adjustment necessary to produce the desired clinical result.
Certain shape memory alloys may further include a rhombohedral phase, having a rhombohedral start temperature (Rs) and a rhombohedral finish temperature (Rf), that exists between the austenite and martensite phases. An example of such a shape memory alloy is a NiTi alloy, which is commercially available from Memry Corporation (Bethel, Connecticut). In certain embodiments, an exemplary Rs temperature range is between approximately 30 degrees Celsius and approximately 50 degrees Celsius, and an exemplary Rf temperature range is between approximately 20 degrees Celsius and approximately 35 degrees Celsius. One benefit of using a shape memory material having a rhombohedral phase is that in the rhomobohedral phase the shape memory material may experience a partial physical distortion, as compared to the generally rigid structure of the austenite phase and the generally deformable structure of the martensite phase.
Certain shape memory alloys exhibit a ferromagnetic shape memory effect wherein the shape memory alloy transforms from the martensite phase to the austenite phase when exposed to an external magnetic field. The term “ferromagnetic” as used herein is a broad term and is used in its ordinary sense and includes, without limitation, any material that easily magnetizes, such as a material having atoms that orient their electron spins to conform to an external magnetic field. Ferromagnetic materials include permanent magnets, which can be magnetized through a variety of modes, and materials, such as metals, that are attracted to permanent magnets. Ferromagnetic materials also include ceramic magnets, which are electrically non-conductive ferrimagnetic ceramic compound materials comprising various mixtures of iron oxides such as Hematite or Magnetite and the oxides of other metals. Ferromagnetic materials also include electromagnetic materials that are capable of being activated by an electromagnetic transmitter, such as one located outside the heart 100. Furthermore, ferromagnetic materials may include one or more polymer-bonded magnets, wherein magnetic particles are bound within a polymer matrix, such as a biocompatible polymer. The magnetic materials can comprise isotropic and/or anisotropic materials, such as for example NdFeB (Neodynium Iron Boron), SmCo (Samarium Cobalt), ferrite and/or AlNiCo (Aluminum Nickel Cobalt) particles.
Thus, an annuloplasty ring comprising a ferromagnetic shape memory alloy can be implanted in a first configuration having a first shape and later changed to a second configuration having a second (e.g., memorized) shape without heating the shape memory material above the As temperature. Advantageously, nearby healthy tissue is not exposed to high temperatures that could damage the tissue. Further, since the ferromagnetic shape memory alloy does not need to be heated, the size of the annuloplasty ring can be adjusted more quickly and more uniformly than by heat activation.
Exemplary ferromagnetic shape memory alloys include Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, Co—Ni—Al, and the like. Certain of these shape memory materials may also change shape in response to changes in temperature. Thus, the shape of such materials can be adjusted by exposure to a magnetic field, by changing the temperature of the material, or both.
In certain embodiments, combinations of different shape memory materials are used. For example, annuloplasty rings according to certain embodiments comprise a combination of shape memory polymer and shape memory alloy (e.g., NiTi). In certain such embodiments, an annuloplasty ring comprises a shape memory polymer tube and a shape memory alloy (e.g., NiTi) disposed within the tube. Such embodiments are flexible and allow the size and shape of the shape memory to be further reduced without impacting fatigue properties. In addition, or in other embodiments, shape memory polymers are used with shape memory alloys to create a bi-directional (e.g., capable of expanding and contracting) annuloplasty ring. Bi-directional annuloplasty rings can be created with a wide variety of shape memory material combinations having different characteristics.
In the following description, reference is made to the accompanying drawings, which form a part hereof, and which show, by way of illustration, specific embodiments or processes in which the invention may be practiced. Where possible, the same reference numbers are used throughout the drawings to refer to the same or like components. In some instances, numerous specific details are set forth in order to provide a thorough understanding of the present disclosure. The present disclosure, however, may be practiced without the specific details or with certain alternative equivalent components and methods to those described herein. In other instances, well-known components and methods have not been described in detail so as not to unnecessarily obscure aspects of the present disclosure.
The receptacle end accepts the insert end 116 of the tubular member 112 to complete the ring-like structure of the annuloplasty ring 100. The insert end 116 slides freely within the receptacle end 114 of the annuloplasty ring 100 which allows contraction of the overall circumference of the ring 100 as the insert end 116 enters the receptacle end 114 as shown by arrows 118 in
An artisan will recognize from the disclosure herein that in other embodiments the insert end 116 can couple with the receptacle end 114 without being inserted in the receptacle end 114. For example, the insert end 116 can overlap the receptacle end 114 such that it slides adjacent thereto. In other embodiments, for example, the ends 114, 116 may grooved to guide the movement of the adjacent ends 114, 116 relative to one another. Other embodiments within the scope of the invention will occur to those skilled in the art.
The annuloplasty ring 100 also comprises a suturable material 128, shown partially cut away in
As shown in
In certain embodiments, the tubular member 112 comprises a rigid material such as stainless steel, titanium, or the like, or a flexible material such as silicon rubber, Dacron®, or the like. In certain such embodiments, after implantation into a patient's body, the circumference of the annuloplasty ring 100 is adjusted in vivo by inserting a catheter (not shown) into the body and pulling a wire (not shown) attached to the tubular member 112 through the catheter to manually slide the insert end 116 of the tubular member 112 into the receptacle end 114 of the tubular member 112. As the insert end 116 slides into the receptacle end 114, the pawl 122 of the ratchet member 120 engages the slots 124 on the insert end 116 to hold the insert end 116 in the receptacle end 114. Thus, for example, as the size of a heart valve annulus reduces after implantation of the annuloplasty ring 100, the size of the annuloplasty ring 100 can also be reduced to provide an appropriate amount of reinforcement to the heart valve.
In certain other embodiments, the tubular member 112 comprises a shape memory material that is responsive to changes in temperature and/or exposure to a magnetic field. As discussed above, the shape memory material may include shape memory polymers (e.g., polylactic acid (PLA), polyglycolic acid (PGA)) and/or shape memory alloys (e.g., nickel-titanium) including ferromagnetic shape memory alloys (e.g., Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, Co—Ni—Al). In certain such embodiments, the annuloplasty ring 100 is adjusted in vivo by applying an energy source such as radio frequency energy, X-ray energy, microwave energy, ultrasonic energy such as high intensity focused ultrasound (HIFU) energy, light energy, electric field energy, magnetic field energy, combinations of the foregoing, or the like. Preferably, the energy source is applied in a non-invasive manner from outside the body. For example, as discussed above, a magnetic field and/or RF pulses can be applied to the annuloplasty ring 100 within a patient's body with an apparatus external to the patient's body such as is commonly used for magnetic resonance imaging (MRI). However, in other embodiments, the energy source may be applied surgically such as by inserting a catheter into the body and applying the energy through the catheter.
In certain embodiments, the tubular body member 112 comprises a shape memory material that responds to the application of temperature that differs from a nominal ambient temperature, such as the nominal body temperature of 37 degrees Celsius for humans. The tubular member 112 is configured to respond by starting to contract upon heating the tubular member 112 above the As temperature of the shape memory material. In certain such embodiments, the annuloplasty ring 100 has an initial diameter or transverse dimension 123 of approximately 30 mm, and contracts or shrinks to a transverse dimension 123 of approximately 23 mm to approximately 28 mm, or any increment between those values. This produces a contraction percentage in a range between approximately 6 percent and approximately 23 percent, where the percentage of contraction is defined as a ratio of the difference between the starting diameter and finish diameter divided by the starting diameter.
The activation temperatures (e.g., temperatures ranging from the As temperature to the Af temperature) at which the tubular member 112 contracts to a reduced circumference may be selected and built into the annuloplasty ring 100 such that collateral damage is reduced or eliminated in tissue adjacent the annuloplasty ring 100 during the activation process. Exemplary Af temperatures for the shape memory material of the tubular member 112 at which substantially maximum contraction occurs are in a range between approximately 38 degrees Celsius and approximately 76 degrees Celsius. In certain embodiments, the Af temperature is in a range between approximately 39 degrees Celsius and approximately 75 degrees Celsius. For some embodiments that include shape memory polymers for the tubular member 112, activation temperatures at which the glass transition of the material or substantially maximum contraction occur range between approximately 38 degrees Celsius and approximately 60 degrees Celsius. In other such embodiments, the activation temperature is in a range between approximately 40 degrees Celsius and approximately 59 degrees Celsius.
In certain embodiments, the tubular member 112 is shape set in the austenite phase to a remembered configuration during the manufacturing of the tubular member 112 such that the remembered configuration is that of a relatively small circumferential value with the insert end 116 fully inserted into the receptacle end 114. After cooling the tubular member 112 below the Mf temperature, the tubular member 112 is manually deformed to a larger circumferential value with the insert end 116 only partially inserted into the receptacle end 114 to achieve a desired starting nominal circumference for the annuloplasty ring 100. In certain such embodiments, the tubular member 112 is sufficiently malleable in the martensite phase to allow a user such as a physician to adjust the circumferential value by hand to achieve a desired fit with the heart valve annulus. In certain embodiments, the starting nominal circumference for the annuloplasty ring 100 is configured to improve leaflet coaptation and reduce regurgitation in a heart valve.
After implantation, the annuloplasty ring 100 is preferably activated non-invasively by the application of energy to the patient's body to heat the tubular member 112. In certain embodiments, an MRI device is used as discussed above to heat the tubular member 112, which then causes the shape memory material of the tubular member 112 to transform to the austenite phase and remember its contracted configuration. Thus, the circumference of the annuloplasty ring 100 is reduced in vivo without the need for surgical intervention. Standard techniques for focusing the magnetic field from the MRI device onto the annuloplasty ring 100 may be used. For example, a conductive coil can be wrapped around the patient in an area corresponding to the annuloplasty ring 100. In other embodiments, the shape memory material is activated by exposing it other sources of energy, as discussed above.
The circumference reduction process, either non-invasively or through a catheter, can be carried out all at once or incrementally in small steps at different times in order to achieve the adjustment necessary to produce the desired clinical result. If heating energy is applied such that the temperature of the tubular member 112 does not reach the Af temperature for substantially maximum transition contraction, partial shape memory transformation and contraction may occur.
As graphically illustrated in
Whether the shape change is continuous or stepped, the diameter or transverse dimension 123 of the ring 100 can be assessed or monitored during the contraction process to determine the amount of contraction by use of MRI imaging, ultrasound imaging, computed tomography (CT), X-ray or the like. If magnetic energy is being used to activate contraction of the ring 100, for example, MRI imaging techniques can be used that produce a field strength that is lower than that required for activation of the annuloplasty ring 100.
In certain embodiments, the tubular member 112 comprises an energy absorption enhancement material 126. As shown in
As discussed above, the energy absorption enhancement material 126 may include a material or compound that selectively absorbs a desired heating energy and efficiently converts the non-invasive heating energy to heat which is then transferred by thermal conduction to the tubular member 112. The energy absorption enhancement material 126 allows the tubular member 112 to be actuated and adjusted by the non-invasive application of lower levels of energy and also allows for the use of non-conducting materials, such as shape memory polymers, for the tubular member 112. For some embodiments, magnetic flux ranging between about 2.5 Tesla and about 3.0 Tesla may be used for activation. In certain embodiments, magnetic flux ranging between 2.0 Tesla and 3.5 Tesla may be used for activation. By allowing the use of lower energy levels, the energy absorption enhancement material 126 also reduces thermal damage to nearby tissue. Suitable energy absorption enhancement materials 126 are discussed above.
In certain embodiments, a circumferential contraction cycle can be reversed to induce an expansion of the annuloplasty ring 100. Some shape memory alloys, such as NiTi or the like, respond to the application of a temperature below the nominal ambient temperature. After a circumferential contraction cycle has been performed, the tubular member 112 is cooled below the Ms temperature to start expanding the annuloplasty ring 100. The tubular member 112 can also be cooled below the Mf temperature to finish the transformation to the martensite phase and reverse the contraction cycle. As discussed above, certain polymers also exhibit a two-way shape memory effect and can be used to both expand and contract the annuloplasty ring 100 through heating and cooling processes. Cooling can be achieved, for example, by inserting a cool liquid onto or into the annuloplasty ring 100 through a catheter, or by cycling a cool liquid or gas through a catheter placed near the annuloplasty ring 100. Exemplary temperatures for a NiTi embodiment for cooling and reversing a contraction cycle range between approximately 20 degrees Celsius and approximately 30 degrees Celsius.
In certain embodiments, external stresses are applied to the tubular member 112 during cooling to expand the annuloplasty ring 100. In certain such embodiments, one or more biasing elements (not shown) are operatively coupled to the tubular member 112 so as to exert a circumferentially expanding force thereon. For example, in certain embodiments a biasing element such as a spring (not shown) is disposed in the receptacle end 114 of the tubular member 112 so as to push the insert end 16 at least partially out of the receptacle end 114 during cooling. In such embodiments, the tubular member 112 does not include the ratchet member 120 such that the insert end 116 can slide freely into or out of the receptacle end 114.
In certain embodiments, the tubular member comprises ferromagnetic shape memory material, as discussed above. In such embodiments, the diameter of the tubular member 112 can be changed by exposing the tubular member 112 to a magnetic field. Advantageously, nearby healthy tissue is not exposed to high temperatures that could damage the tissue. Further, since the shape memory material does not need to be heated, the size of the tubular member 112 can be adjusted more quickly and more uniformly than by heat activation.
For embodiments of the annuloplasty ring 400 with a tubular member 410 made from a continuous piece of shape memory alloy (e.g., NiTi alloy) or shape memory polymer, the annuloplasty ring 400 can be activated by the surgical and/or non-invasive application of heating energy by the methods discussed above with regard to other embodiments. For embodiments of the annuloplasty ring 400 with a tubular member 410 made from a continuous piece of ferromagnetic shape memory alloy, the annuloplasty ring 400 can be activated by the non-invasive application of a suitable magnetic field. The annuloplasty ring 400 has a nominal inner diameter or transverse dimension indicated by arrow 412 in
In certain embodiments, upon activating the tubular member 410 by the application of energy, the tubular member 410 remembers and assumes a configuration wherein the transverse dimension is less than the nominal transverse dimension 412. A contraction in a range between approximately 6 percent to approximately 23 percent may be desirable in some embodiments which have continuous hoops of shape memory tubular members 410. In certain embodiments, the tubular member 410 comprises a shape memory NiTi alloy having an inner transverse dimension in a range between approximately 25 mm and approximately 38 mm. In certain such embodiments, the tubular member 410 can contract or shrink in a range between approximately 6 percent and approximately 23 percent, where the percentage of contraction is defined as a ratio of the difference between the starting diameter and finish diameter divided by the starting diameter. In certain embodiments, the annuloplasty ring 400 has a nominal inner transverse dimension 412 of approximately 30 mm and an inner transverse dimension in a range between approximately 23 mm and approximately 128 mm in a fully contracted state.
As discussed above in relation to
Alternatively, the tubular member 510 may comprise two or more sections or zones of shape memory material having different temperature response curves. The shape memory response zones may be configured in order to achieve a desired configuration of the annuloplasty ring 500 as a whole when in a contracted state, either fully contracted or partially contracted. For example, the tubular member 510 may have a first zone or section 514 that includes the arched portion of the tubular member that terminates at or near the corners 516 and a second zone or section 518 that includes the substantially straight portion of the tubular member 510 disposed directly between the corners 516.
The annuloplasty ring 500 is shown in a contracted state in
For purposes of discussion, the wire 600 is shown relative to a first reference point 614, a second reference point 616 and a third reference point 618. The radius of the substantially semi-circular portion 612 is defined with respect to the first reference point 614 and the corner portions 610 are respectively defined with respect to the second reference point 616 and the third reference point 618. Also for purposes of discussion,
In certain embodiments, the first transverse dimension A is in a range between approximately 20.0 mm and approximately 40.0 mm, the second transverse dimension B is in a range between approximately 10.0 mm and approximately 25.0 mm. In certain such embodiments, the wire 600 comprises a rod having a diameter in a range between approximately 0.45 mm and approximately 0.55 mm, the radius of each corner portion 610 is in a range between approximately 5.8 mm and 7.2 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 11.5 mm and approximately 14.0 mm. In certain other such embodiments, the wire 600 comprises a rod having a diameter in a range between approximately 0.90 mm and approximately 1.10 mm, the radius of each corner portion 610 is in a range between approximately 6.1 mm and 7.4 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 11.7 mm and approximately 14.3 mm.
In certain other embodiments, the first transverse dimension A is in a range between approximately 26.1 mm and approximately 31.9 mm, the second transverse dimension B is in a range between approximately 20.3 mm and approximately 24.9 mm. In certain such embodiments, the wire 600 comprises a rod having a diameter in a range between approximately 0.4 mm and approximately 0.6 mm, the radius of each corner portion 610 is in a range between approximately 6.7 mm and 8.3 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 13.3 mm and approximately 16.2 mm. In certain other such embodiments, the wire 600 comprises a rod having a diameter in a range between approximately 0.90 mm and approximately 1.10 mm, the radius of each corner portion 610 is in a range between approximately 6.9 mm and 8.5 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 13.5 mm and approximately 16.5 mm.
In certain embodiments, the wire 600 comprises a NiTi alloy configured to transition to its austenite phase when heated so as to transform to a memorized shape, as discussed above. In certain such embodiments, the first transverse dimension A of the wire 600 is configured to be reduced by approximately 10% to 25% when transitioning to the austenite phase. In certain such embodiments, the austenite start temperature As is in a range between approximately 33 degrees Celsius and approximately 43 degrees Celsius, the austenite finish temperature Af is in a range between approximately 45 degrees Celsius and approximately 55 degrees Celsius, the martensite start temperature Ms is less than approximately 30 degrees Celsius, and the martensite finish temperature Mf is greater than approximately 20 degrees Celsius. In other embodiments, the austenite finish temperature Af is in a range between approximately 48.75 degrees Celsius and approximately 51.25 degrees Celsius. Other embodiments can include other start and finish temperatures for martensite, rhombohedral and austenite phases as described herein.
In certain embodiments, the shape memory wire 600 is configured to bow in the third dimension a distance in a range between approximately 2 millimeters and approximately 10 millimeters. In certain embodiments, the shape memory wire 600 is implanted so as to bow towards the atrium when implanted around a cardiac valve annulus to accommodate the natural shape of the annulus. In other embodiments, the shape memory wire 600 is configured to bow towards the ventricle when implanted around a cardiac valve to accommodate the natural shape of the annulus.
In certain embodiments, the shape memory wire 600 is bowed in the third dimension, as shown in
For purposes of discussion, the wire 800 is shown relative to a first reference point 814, a second reference point 816 and a third reference point 818. The radius of the substantially semi-circular portion 812 is defined with respect to the first reference point 814 and the corner portions 810 are respectively defined with respect to the second reference point 816 and the third reference point 818. Also for purposes of discussion,
In certain embodiments, the wire 800 comprises a NiTi alloy configured to transition to its austenite phase when heated so as to transform to a memorized shape, as discussed above. In certain such embodiments, the first transverse dimension A of the wire 800 is configured to be reduced by approximately 10% to 25% when transitioning to the austenite phase. In certain such embodiments, the austenite start temperature As is in a range between approximately 33 degrees Celsius and approximately 43 degrees Celsius, the austenite finish temperature Af is in a range between approximately 45 degrees Celsius and approximately 55 degrees Celsius, the martensite start temperature Ms is less than approximately 30 degrees Celsius, and the martensite finish temperature Mf is greater than approximately 20 degrees Celsius. In other embodiments, the austenite finish temperature Af is in a range between approximately 48.75 degrees Celsius and approximately 51.25 degrees Celsius.
The annuloplasty ring 1000 comprises a first shape memory wire 1010 for contracting the annuloplasty ring 1000 and a second shape memory wire 1012 for expanding the annuloplasty ring 1000. The first and second shape memory wires, 1010, 1012 are covered by the flexible material 912 and the suturable material 914 shown in
In certain embodiments, the annuloplasty ring 1000 is heated to a first temperature that causes the first shape memory wire 1010 to transition to its austenite phase and contract to its memorized shape. At the first temperature, the second shape memory wire 1012 is in its martensite phase and is substantially flexible as compared the contracted first shape memory wire 1010. Thus, when the first shape memory wire 1010 transitions to its austenite phase, it exerts a sufficient force on the second shape memory wire 1012 through the flexible material 912 to deform the second shape memory wire 1012 and cause the annuloplasty ring 1000 to contract.
The annuloplasty ring 1000 can be expanded by heating the annuloplasty ring to a second temperature that causes the second shape memory wire 1012 to transition to its austenite phase and expand to its memorized shape. In certain embodiments, the second temperature is higher than the first temperature. Thus, at the second temperature, both the first and second shape memory wires 1010, 1012 are in their respective austenite phases. In certain such embodiments, the diameter of the second shape memory wire 1012 is sufficiently larger than the diameter of the first shape memory wire 1010 such that the second memory shape wire 1012 exerts a greater force to maintain its memorized shape in the austenite phase than the first shape memory wire 1010. Thus, the first shape memory wire 1010 is mechanically deformed by the force of the second memory shape wire 1012 and the annuloplasty ring 1000 expands.
In certain embodiments, the first memory shape wire 1010 is configured to contract by approximately 10% to 25% when transitioning to its austenite phase. In certain such embodiments, the first memory shape wire 1010 has an austenite start temperature As in a range between approximately 33 degrees Celsius and approximately 43 degrees Celsius, an austenite finish temperature Af in a range between approximately 45 degrees Celsius and approximately 55 degrees Celsius, a martensite start temperature Ms less than approximately 30 degrees Celsius, and a martensite finish temperature Mf greater than approximately 20 degrees Celsius. In other embodiments, the austenite finish temperature Af of the first memory shape wire 1010 is in a range between approximately 48.75 degrees Celsius and approximately 51.25 degrees Celsius.
In certain embodiments, the second memory shape wire 1012 is configured to expand by approximately 10% to 25% when transitioning to its austenite phase. In certain such embodiments, the second memory shape wire 1010 has an austenite start temperature As in a range between approximately 60 degrees Celsius and approximately 70 degrees Celsius, an austenite finish temperature Af in a range between approximately 65 degrees Celsius and approximately 75 degrees Celsius, a martensite start temperature Ms less than approximately 30 degrees Celsius, and a martensite finish temperature Mf greater than approximately 20 degrees Celsius. In other embodiments, the austenite finish temperature Af of the first memory shape wire 1010 is in a range between approximately 68.75 degrees Celsius and approximately 71.25 degrees Celsius.
The first shape memory wire 1010 comprises a first coating 1120 and the second shape memory wire 1012 comprises a second coating 1122. In certain embodiments, the first coating 1120 and the second coating 1122 each comprise silicone tubing configured to provide suture attachment to a heart valve annulus. In certain other embodiments, the first coating 1120 and the second coating 1122 each comprise an energy absorption material, such as the energy absorption materials discussed above. In certain such embodiments, the first coating 1120 heats when exposed to a first form of energy and the second coating 1122 heats when exposed to a second form of energy. For example, the first coating 1120 may heat when exposed to MRI energy and the second coating 1122 may heat when exposed to HIFU energy. As another example, the first coating 1120 may heat when exposed to RF energy at a first frequency and the second coating 1122 may heat when exposed to RF energy at a second frequency. Thus, the first shape memory wire 1010 and the second shape memory wire 1012 can be activated independently such that one transitions to its austenite phase while the other remains in its martensite phase, resulting in contraction or expansion of the annuloplasty ring 1100.
As discussed above, an electrical current can be non-invasively induced in the coil 1210 using electromagnetic energy. For example, in certain embodiments, a handheld or portable device (not shown) comprising an electrically conductive coil generates an electromagnetic field that non-invasively penetrates the patient's body and induces a current in the coil 1210. The electrical current causes the coil 1210 to heat. The coil 1210, the wire 800 and the coating (if any) are thermally conductive so as to transfer the heat or thermal energy from the coil 1210 to the wire 800. Thus, thermal energy can be directed to the wire 800, or portions thereof, while reducing thermal damage to surrounding tissue.
Although not shown in
For some indications, it may be desirable for an adjustable annuloplasty ring to have some compliance in order to allow for expansion and contraction of the ring in concert with the expansion and contraction of the heart during the beating cycle or with the hydrodynamics of the pulsatile flow through the valve during the cycle. As such, it may be desirable for an entire annuloplasty ring, or a section or sections thereof, to have some axial flexibility to allow for some limited and controlled expansion and contraction under clinical conditions.
For embodiments where the coil 1412 is made of NiTi alloy or other shape memory material, the ring 1400 is responsive to temperature changes which may be induced by the application of heating energy on the coil 1412. In certain embodiments, if the temperature is raised, the coil 1412 will contract axially or circumferentially such that an inner transverse dimension of the ring 1400 decreases, as shown by the dashed lines in
The embodiments of
In certain embodiments, the shape memory materials of the various temperature response zones 1602, 1604, 1606, 1608 are selected to have temperature responses and reaction characteristics such that a desired shape and configuration can be achieved in vivo by the application of invasive or non-invasive energy, as discussed above. In addition to general contraction and expansion changes, more subtle changes in shape and configuration for improvement or optimization of valve function or hemodynamics may be achieved with such embodiments.
According to certain embodiments, the first zone 1602 and second zone 1604 of the ring 1600 are made from a shape memory material having a first shape memory temperature response. The third zone 1606 and fourth zone 1608 are made from a shape memory material having a second shape memory temperature response. In certain embodiments, the four zones comprise the same shape memory material, such as NiTi alloy or other shape memory material as discussed above, processed to produce the varied temperature response in the respective zones. In other embodiments, two or more of the zones may comprise different shape memory materials. Certain embodiments include a combination of shape memory alloys and shape memory polymers in order to achieve the desired results.
According to certain embodiments,
In certain other embodiments, the zones 1602, 1604 are configured to expand or contract by virtue of the shape memory mechanism at a temperature in a range between approximately 50 degrees Celsius and approximately 60 degrees Celsius. In certain such embodiments, the zones 1606, 1608 are configured to respond at a temperature in a range between approximately 39 degrees Celsius and approximately 45 degrees Celsius.
In certain embodiments, the materials, dimensions and features of the annuloplasty ring 1600 and the corresponding zones 1602, 1604, 1606, 1608 have the same or similar features, dimensions or materials as those of the other ring embodiments discussed above. In certain embodiments, the features of the annuloplasty ring 1600 are added to the embodiments discussed above.
According to certain embodiments,
In certain situations, it is advantageous to reshape a heart valve annulus in one dimension while leaving another dimension substantially unchanged or reshaped in a different direction. For example,
In certain embodiments, the annuloplasty ring 1826 comprises a first marker 1830 and a second marker 1832 that are aligned with the first commissure 1818 and the second commissure 1820, respectively, when the annuloplasty ring 1826 is implanted around the mitral valve 1810. In certain embodiments, the first marker 1830 and the second marker 1832 comprise materials that can be imaged in-vivo using standard imaging techniques. For example, in certain embodiments, the markers 1830 comprise radiopaque markers or other imaging materials, as is known in the art. Thus, the markers 1830, 1832 can be used for subsequent procedures for alignment with the annuloplasty ring 1826 and/or the commissures 1818, 1820. For example, the markers 1830, 1832 can be used to align a percutaneous energy source, such as a heated balloon inserted through a catheter, with the annuloplasty ring 1826.
When the shape memory material is activated, the annuloplasty ring 1826 contracts in the direction of the arrow 1824 to push the anterior leaflet 1812 toward the posterior leaflet 1814. Such anterior/posterior contraction improves the coaptation of the leaflets 1812, 1814 such that the gap 1824 between the leaflets 1812, 1814 sufficiently closes during left ventricular contraction. In certain embodiments, the annuloplasty ring 1826 also expands in the direction of arrows 1834. Thus, the first commissure 1818 and the second commissure 1820 are pulled away from each other, which draws the leaflets 1812, 1814 closer together and further improves their coaptation. However, in certain other embodiments, the annuloplasty ring does not expand in the direction of the arrows 1834. In certain such embodiments, the distance between the lateral portions of the annuloplasty ring 1826 between the anterior portion and the posterior portion (e.g., the lateral portions approximately correspond to the locations of the markers 1830, 1832 in the embodiment shown in
When the shape memory material is activated, the wire 800 is configured to respond by contracting in a first direction as indicated by arrow 1824. In certain embodiments, the wire 800 also expands in a second direction as indicated by arrows 1834. Thus, the wire 800 is usable by the annuloplasty ring 1826 shown in
The body member 2000 comprises a wire 2010 and a shape memory tube 2012. As used herein, the terms “tube,” “tubular member” and “tubular structure” are broad terms having at least their ordinary and customary meaning and include, for example, hollow elongated structures that may in cross-section be cylindrical, elliptical, polygonal, or any other shape. Further, the hollow portion of the elongated structure may be filled with one or more materials that may be the same as and/or different than the material of the elongated structure. In certain embodiments, the wire 2010 comprises a metal or metal alloy such as stainless steel, titanium, platinum, combinations of the foregoing, or the like. As used herein, the term “wire” is a broad term having at least its ordinary and customary meaning and includes, for example, solid, hollow or tubular elongated structures that may in cross-section be cylindrical, elliptical, polygonal, or any other shape, including a substantially flat ribbon shape. In certain embodiments, the shape memory tube 2012 comprises shape memory materials formed in a tubular structure through which the wire 2010 is inserted. In certain other embodiments, the shape memory tube 2012 comprises a shape memory material coated over the wire 2010. Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above. Although not shown, in certain embodiments, the body member 2000 comprises an energy absorption enhancement material, as discussed above.
The body member 2100 comprises a wire 2010, such as the wire 2010 shown in
In certain embodiments, the shape memory tube 2112 comprises a first shape memory material 2114 and a second shape memory material 2116 formed in a tubular structure through which the wire 2010 is inserted. In certain such embodiments, the first shape memory material 2114 and the second shape memory material 2116 are each configured as a semi-circular portion of the tubular structure. For example,
In certain embodiments, the first shape memory material 2114 can then be activated to bend the body member 2100 opposite to the first direction as indicated by arrow 2118. In certain such embodiments, the body member 2100 is reshaped to the first configuration as shown in
The first shape memory band 2410 is configured to loop back on itself to form a substantially C-shaped configuration. However, an artisan will recognize from the disclosure herein that the first shape memory band 2410 can be configured to loop back on itself in other configurations including, for example, circular, D-shaped, or other curvilinear configurations. When activated, the first shape memory band 2410 expands or contracts such that overlapping portions of the band 2410 slide with respect to one another, changing the overall shape of the body member 2400. The second shape memory band 2412 is disposed along a surface of the first shape memory band 2410 such that the second shape memory band 2412 is physically deformed when the first shape memory band 2410 is activated, and the first shape memory band 2410 is physically deformed when the second shape memory band 2412 is activated.
As shown in
While the first shape memory band 2410 and the second shape memory band 2412 shown in
An artisan will recognize from the disclosure herein that certain embodiments of the body member 2400 may not comprise either the first shape memory band 2410 or the second shape memory band 2412. For example, in certain embodiments the body member 2400 does not include the second shape memory band 2412 and is configured to expand and/or contract by only activating the first shape memory band 2410. Further, an artisan will recognize from the disclosure herein that either the first band 2410 or the second band 2412 may not comprise a shape memory material. For example, the first band 2410 may titanium, platinum, stainless steel, combinations of the foregoing, or the like and may be used with or without the second band 2412 to support a coronary valve annulus.
As schematically illustrated in
In certain embodiments, the second shape memory band 2412 can then be activated to further contract the body member 2400 in the direction of the arrow 1824 and, in certain embodiments, further expand the body member 2400 in the direction of arrows 1834. In certain such embodiments, activating the second shape memory band 2412 reshapes the body member 2400 to a third configuration as shown in
In certain annuloplasty ring embodiments, flexible materials and/or suturable materials used to cover shape memory materials also thermally insulate the shape memory materials so as to increase the time required to activate the shape memory materials through application of thermal energy. Thus, surrounding tissue is exposed to the thermal energy for longer periods of time, which may result in damage to the surrounding tissue. Therefore, in certain embodiments of the invention, thermally conductive materials are configured to penetrate the flexible materials and/or suturable materials so as to deliver thermal energy to the shape memory materials such that the time required to activate the shape memory materials is decreased.
For example,
In certain embodiments, the thermal conductors 2610, 2612, 2614 comprise a thin (e.g., having a thickness in a range between approximately 0.002 inches and approximately 0.015 inches) wire wrapped around the outside of the suturable material 914 and penetrating the suturable material 914 and the flexible material 912 at one or more locations 2618 so as to transfer externally applied heat energy to the shape memory wire 800. For example,
In the exemplary embodiment shown in
In the exemplary embodiment shown in
Referring again to
In addition, or in other embodiments, the thermal conductors 2610, 2612, 2614 are located so as to mark desired positions on the annuloplasty ring 2600. For example, the thermal conductors 2610, 2612, 2614 may be disposed at locations on the annuloplasty ring 2600 corresponding to commissures of heart valve leaflets, as discussed above with respect to
In certain embodiments, the shape memory wire 800 is not sufficiently thermally conductive so as to quickly transfer heat applied in the areas of the thermal conductors 2810, 2812, 2814, 2816, 2818. Thus, in certain such embodiments, the annuloplasty ring 2800 comprises a thermal conductor 2820 that runs along the length of the shape memory wire 800 so as to transfer heat to points of the shape memory wire 800 extending beyond or between the thermal conductors 2810, 2812, 2814, 2816, 2818. In certain embodiments, each of the thermal conductors 2810, 2812, 2814, 2816, 2818, comprise a separate thermally conductive wire configured to transfer heat to the thermal conductive wire 2820. However, in certain other embodiments, at least two of the thermal conductors 2810, 2812, 2814, 2816, 2818 and the thermal conductor 2820 comprise one continuous thermally conductive wire.
Thus, thermal energy can be quickly transferred to the annuloplasty ring 2600 or the annuloplasty ring 2800 to reduce the amount of energy required to activate the shape memory wire 800 and to reduce thermal damage to the patient's surrounding tissue.
The adjustable rings described above can be implanted in the heart to improve the efficacy of the heart. For example, one or more adjustable rings can be implanted in the heart to improve the function (e.g., leaflet operation) of a heart valve. Adjustable rings can help reduce or prevent reverse flow or regurgitation while preferably permitting good hemodynamics during forward flow. Of course, the adjustable rings can be employed for other treatments.
After a treatment period, the efficacy of the heart may degrade, or the heart may be ready to undergo further treatment. At some point after implantation of the adjustable ring, the adjustable ring can be activated to change its configuration (e.g., its shape). The adjustable ring can be activated minutes, hours, days, months, and/or years after implantation. In some embodiments, the adjustable ring can be activated immediately after the adjustable ring is implanted into the patient. The adjustable ring may be activated one or more times depending on the particular treatment. A physician can perform tests, as are known in the art, to determine if the patient should undergo further treatment after implantation of the ring.
Magnetically Engageable Embodiments
In certain embodiments, the annuloplasty ring 2900 comprises a shape memory wire covered by a flexible material and a suturable material, such as the wire 800, the flexible material 912 and the suturable material 914 shown in
The tubular member 2910 may comprise a homogeneous shape memory material, such as a shape memory polymer or a shape memory alloy including, for example, a ferromagnetic shape memory alloy. Alternatively, the tubular member 2910 may comprise two or more sections or zones of shape memory material having different temperature response curves, as discussed above with reference to
In certain embodiments, one or more of the magnetic devices 2914 and 2916 can produce a force in a range between approximately 0.2 pounds of force and approximately 2.0 pounds of force at a distance of between one millimeter to ten millimeters, with a magnetic field in a range between approximately 100 Gauss and approximately 10,000 Gauss. In certain embodiments, a magnetic device may produce a force in a range between 0.1 pounds of force and 3.0 pounds of force at a distance between 0.5 millimeters and twenty millimeters. In certain embodiments, a magnetic device may produce a force in a range between 0.05 pounds of force and 5.0 pounds of force. In certain embodiments, the magnetic field may have a range between approximately 100 gauss and approximately 700 gauss. In certain embodiments, the magnetic field may have a range between approximately 50 gauss and approximately 15,000 gauss.
The magnetic devices 2914 and 2916 may have any suitable configuration provided they are suitably biocompatible or covered with a biocompatible material for implantation in the human body, as discussed above.
In certain embodiments, the magnetic devices 2914 and 2916 are cylindrical shaped magnets having a positive pole and a negative pole. In certain such embodiments, one or more of the magnetic devices 2914 and 2916 has a diameter in a range between approximately 0.2 mm and approximately 0.4 mm, and a height in a range between approximately 0.2 mm and approximately 0.4 mm, which facilitates attachment of the magnetic devices 2914 and 2916 to the annuloplasty ring 2900. In other embodiments, the magnetic devices 2914 and 2916 may have other shapes. For example, in certain embodiments, one or more of the magnetic devices 2914 and 2916 can be in the shape of a rod, a sphere, a disk, a cube, a band, or the like. In certain embodiments, the magnets may have a different number of poles. In certain embodiments where the magnetic devices as disposed about the tubular member 2910, the magnetic devices may take the shape of a band around the tubular member.
In certain embodiments, the features, dimensions and materials of the annuloplasty ring 2900 are the same as or similar to the features, dimensions and materials of the annuloplasty ring 100 discussed above. certain embodiments, the tubular member 2910 may be made of at least a portion of shape memory material.
A suturable material (not shown), such as the suturable material 128 shown in
The annuloplasty ring 2900 comprises one or more magnetic devices 2914 and 2916. In certain embodiments (not illustrated), the annuloplasty ring 2900 comprises one magnetic device, while in other embodiments, the annuloplasty ring 2900 comprises a plurality of magnetic devices. In certain embodiments, a magnetic device is located at only one end of the annuloplasty ring 2900, while in other embodiments, magnetic devices are located at both ends of the annuloplasty ring 2900. In certain embodiments, a magnetic device defines an end of the annuloplasty ring 2900, as shown in
The term “magnetic” as used herein is a broad term and is used in its ordinary sense and includes, without limitation, any material that easily magnetizes, such as a material having atoms that orient their electron spins to conform to an external magnetic field. The magnetic devices 2914 and 2916 comprise materials exhibiting magnetic behavior or that may be magnetized by another magnet, including, but not limited to, ferromagnetism (including ferrimagnetism), diamagnetism and paramagnetism. Ferromagnetic materials include permanent magnets, ceramic magnets, electromagnetic materials, one or more polymer-bonded magnets, and isotropic and/or anisotropic materials, as discussed above. The magnetic devices 2914 and 2916 may also conduct thermal energy.
In certain embodiments, at least one of the magnetic devices 2914 and 2916 comprises a magnetic material. In certain embodiments, at least one of the magnetic devices 2914 or 2916 comprises an electromagnet that can be turned on or off. For example,
The tubular member 2910 may comprise a homogeneous shape memory material, such as a shape memory polymer or a shape memory alloy including, for example, a ferromagnetic shape memory alloy. Alternatively, the tubular member 2910 may comprise two or more sections or zones of shape memory material having different temperature response curves, as discussed above with reference to
A suturable material (not shown), such as the suturable material 128 shown in
The annuloplasty ring 2902 comprises one or more magnetic devices 2914 and 2916 located between the ends of the annuloplasty ring 2902. The magnetic devices 2914 and 2916 of the annuloplasty ring 2902 comprise one or more magnetic bands disposed about the tubular member 2910. In certain embodiments, In certain embodiments, the annuloplasty ring 2902 may comprise more than one tubular member axially separated by magnetic devices. In certain embodiments, the magnetic bands 2914 and 2916 are located at or near the ends of the annuloplasty ring 2902. In certain embodiments, the magnetic bands 2914 and 2916 are located substantially near the midpoint between the both ends of the annuloplasty ring 2902. In certain embodiments, the one or more magnetic bands 2914 and 2916 are located at various points along the annuloplasty ring 2902. In certain embodiments (not illustrated), the annuloplasty ring 2902 comprises one magnetic device, while in other embodiments, the annuloplasty ring 2902 comprises a plurality of magnetic devices 2914 and 2916.
In certain embodiments, the outside surface of the magnetic devices 2914 and 2916 is coated with a thin coating of biocompatible material as discussed above, including fluorinated ethylene propylene (FEP), polyether ether kythane (PEEK®), polycarbonate, polypropylene, high density polyethylene (HDPE), modified ethylene-tetrafluoroethylene copolymer (ETFE), polyethylene terephthalate polyester (PET-P), polyimide, nylon 6/12, and acrylonitrile/butadiene/styrene resin (ABS). In other embodiments, the suturable material comprises a biological material such as bovine or equine pericardium, homograft, patient graft, or cell-seeded tissue. An outer layer of rigid material, as described above, can also be used.
In certain embodiments, the features, dimensions and materials of the annuloplasty ring 2902 are the same as or similar to the features, dimensions and materials of the annuloplasty ring 100 discussed above.
In certain embodiments, the body member 2000 is configured to enter multiple configurations when activated, as discussed above with reference to
The body member 2000 comprises one or more magnetic devices 2914 and 2916. In certain embodiments (not illustrated), the body member 2000 comprises one magnetic device, while in other embodiments, the body member 2000 comprises a plurality of magnetic devices.
In certain embodiments, the wire 2010 attaches the magnetic devices 2914, 2916 to the first and second ends, respectively, of the body member 2000. In certain embodiments, the wire 2010 wraps around the magnetic devices 2914 and 2916 in a semicircular, or hook-shaped fashion. In other embodiments, the wire 2010 wraps around the magnetic devices 2914 and 2916 in a loop, as illustrated in
Although the embodiments 2900, 2902, and 2000 of
In other embodiments, the magnetic devices can have different orientations. In certain other embodiments, the first magnetic device 2914 can be orientated such that its positive pole is on its top surface, and the second magnetic device 2916 can be oriented such that its negative pole is on its top surface. In certain other embodiments, the first and second magnetic devices 2914 and 2916 can be orientated such that their positive poles are on their respective top surfaces. In certain other embodiments, the first and second magnetic devices 2914 and 2916 can be orientated such that their negative poles are on their respective top surfaces.
The body member 2000 further comprises one or more energy conductors 3110, according to certain embodiments of the invention. In certain embodiments, the conductors 3110 comprise thermal conductors. In certain embodiments, the conductors are configured to conduct other forms of energy, such as radio frequency (RF) energy, x-ray energy, microwave energy, ultrasonic energy such as focused ultrasound, high intensity focused ultrasound (HIFU) energy, light energy, electric field energy, magnetic field energy, combinations of the foregoing, or the like.
In certain embodiments, the conductors 3110 comprise a thin wire wrapped around the outside of the shape memory tube 2012 to transfer externally applied heat energy to the shape memory tube 2012. For example, the wire may have a thickness in a range between approximately 0.002 inches and approximately 0.015 inches. In certain embodiments, the wire may have a thickness in a range between approximately 0.001 inches and approximately 0.080 inches. In certain embodiments, the wire may have a thickness in a range between approximately 0.0005 inches and approximately 0.1 inches. In certain embodiments, the conductors 3110 are attached to one or both of the magnetic devices 2914 and 2916, In certain embodiments, the conductors 3110 may comprise a casing wrapped around the outside of the shape memory tube 2012. In certain embodiments, the conductors 3110 may comprise platinum coated copper, titanium, tantalum, stainless steel, gold, their combinations, or the like, as discussed above.
In certain embodiments, the conductors 3110 comprise heating wire 3110, which that generate heat when activated by an electrically conductive element, such as an electrical source or a heat source. For example, the heating wire 3110 may be activated by a catheter comprising a contact portion that may be heated, as discussed below.
In certain embodiments, the heating wire 3110 comprises a thin wire, such as a nickel-chromium resistance wire or iron-chrome-aluminum wire, wrapped around the outside of the shape memory tube 2012. In certain embodiments, the wire may have a thickness in a range between approximately 0.002 inches and approximately 0.015 inches. In certain embodiments, the wire may have a thickness in a range between approximately 0.001 inches and approximately 0.080 inches. In certain embodiments, the wire may have a thickness in a range between approximately 0.0005 inches and approximately 0.1 inches. In certain embodiments, the heating wire 3110 is encased in a biocompatible material as described above.
In certain embodiments, the heating wire 3110 is attached to one or both of the magnetic devices 2914 and 2916. The wire 3110 transfers heat energy generated or conducted by the wire 3110 to the shape memory tube 2012. For example, if the wire 3110 is heated using an external device, a quantity of the heat from the wire 3110 may pass to the shape memory tube 2012 through a contact point between the two objects in order to heat the shape memory tube 2012 to an austensite temperature.
In certain embodiments, the conductor 3110, such as the heating wire, may not physically contact with the shape memory tube 2012. In certain embodiments, the conductor 3110 can pass around and/or through the covering of an annuloplasty ring, such as annuloplasty rings 1826 or 2600, to transfer heat or electric current to the shape memory tube 2012. In certain embodiments, the conductor 3110 passes sufficiently close to the shape memory tube 2012 so as to decrease the time required to activate the shape memory tube 2012. Thus, the potential for damage to surrounding tissue is reduced.
The catheter 3200 comprises a catheter body portion 3210 at a proximal end of the catheter 3200 and a distal portion 3208 at a distal end of the catheter 3200. The distal portion 3208 comprises a flexible tip portion 3212, which itself comprises a magnetic tip 3214 configured to emanate a magnetic field. For example, the magnetic tip illustrated has a positive pole and a negative pole. In certain embodiments, the flexible tip portion 3212 may be made using flexible material, as described above.
In certain embodiments, the magnetic tip 3214 comprises a ferromagnetic material, as described above. In certain embodiments, the positive pole of the magnetic tip 3214 is at the distal end of the catheter 3200. In certain other embodiments, the negative pole of the magnetic tip 3214 is at the distal end of the catheter 3200. The magnetic tip 3214 can be adhered, welded, soldered, glued, or otherwise incorporated into the distal portion 3208 as desired. In certain embodiments, the magnetic tip 3214 may comprise a plurality of magnetic bands. The magnetic bands can be evenly or unevenly spaced along the length of the distal portion 3208. The magnetic devices 2914 and 2916 of the implantable device 2000 can be positioned at any suitable location to aid in the positioning of the distal portion 3208 of the catheter 3200 relative to the implant 2000.
The body portion 3210 includes a side arm 3204 through which catheter ports 3260 may be accessed. In certain embodiments, the catheter 3200 may contain one port, while in other embodiments the catheter 3200 may contain more than one port. In certain embodiments, the catheter 3200 may not contain any ports. A catheter port 3260 may be used to facilitate the insertion and pushing of instruments or objects, such as heated fluid or a heated fluid balloon, or fiber optic elements through the catheter body 2604 so as to deliver them to heart tissue.
Heart tissue may be accessed during an operation by various techniques and procedures so that the implantable device 2000 can be activated. For example, minimal invasive surgery techniques, laparoscopic procedures, and/or open surgical procedures can provide a convenient access path to the chambers of the heart for delivering energy using the magnetic tipped catheter 3200. In some embodiments, access to the heart can be provided through the chest of a patient, and may include, without limitation, conventional transthoracic surgical approaches, open and semi-open heart procedures, and port access techniques. Such surgical access and procedures preferably can utilize conventional surgical instruments for access and performing surgical procedures on the heart, for example, retractors, rib spreaders, trocars, laparoscopic instruments, forceps, cannulas, staplers, and the like. The implant 2000 can be activated in conjunction with another surgical procedure that provides access (e.g., mitral valve repair, bypass surgical procedures, etc.).
Generally, in an embodiment intended for access through the femoral vein and delivery to the left atrium, the catheter 3200 can have a length within the range of from about 50 cm to about 150 cm, and a diameter of generally no more than about 5 French, 10 French, or 15 French. Those skilled in the art recognize that the catheter system can be configured and sized for various methods of activating the implantable device, as described below. The catheter 3200 can be sized and configured so that it can be delivered using, for example, conventional transthoracic surgical, minimally invasive, or port access approaches. In view of the present disclosure, further dimensions and physical characteristics of catheters for navigation to particular sites within the body are well understood in the art.
In embodiments where the catheter 3200 is delivered percutaneously into the heart, a guiding sheath can be placed in the vasculature system of the patient and used to guide the catheter 3200 to a desired deployment site.
In some embodiments, a guide wire is used to gain access through the superior or inferior vena cava, for example, through groin access for delivery through the inferior vena cava. The guiding sheath can be advanced over the guide wire and into the inferior vena cava. The distal end of the guiding sheath can be passed through the right atrium and towards the septum. Once the distal end of the guiding sheath is positioned proximate to the septum, a needle or piercing member is preferably advanced through the guiding sheath and used to puncture the fossa ovalis or other portion of the septum. In some embodiments, the guiding sheath is dimensioned and sized to pass through the fossa ovalis without requiring a puncturing device. That is, the guiding sheath can pass through the natural anatomical structure of the fossa ovalis into the left atrium.
The guiding sheath can be positioned through the inferior vena cava through the right atrium and a septal hole. When the guiding sheath is positioned within the heart, the catheter 3200 can be advanced distally through the guiding sheath. As the catheter 3200 is advanced through the guiding sheath, the distal portion 3208 is somewhat straight. Thus, the distal portion 3208 can be delivered through a low profile delivery sheath and can flex as it is advanced distally.
The catheter system 3200 can be advanced until the distal portion 3208 passes out of an opening of the guiding sheath. Preferably, the distal portion 3208 is in a generally collapsed state (e.g., a deflated state) as it is delivered through the guiding sheath for a low profile configuration.
As the distal portion 3208 passes out of the opening of the guiding sheath, the distal portion can assume its at-rest configuration. The distal portion 3208 assumes a somewhat curved configuration as it extends out of the opening. Of course, the catheter system 3200 can be twisted and rotated within the guiding sheath to position the distal portion 3208 comprising the magnetic tip 3214.
In some embodiments, the magnetic tip 3214 of the distal portion 3208 can be an atraumatic tip that is configured to slide through the lumen of the delivery sheath. The atraumatic tip 3214 can limit or prevent significant damage to the inner tissue of the heart.
The body member 2000 comprises the first magnetic device 2914 attached to the first end of the body member 2000, the second magnetic device 2916 attached to the second end of the body member 2000, and the conductor 3110.
After the body member 2000 has been implanted into a patient, a first catheter 3200a is inserted into the patient and guided to the annuloplasty implant area, as discussed above. The pole on the outer surface of the first magnetic tip 3214a and pole on the top surface of the first magnet device 2914 are of opposite polarities such that the magnetic tip 3214a and the first magnetic device 2914 produce a mutually attractive force. In certain embodiments, the magnetic tip 3214a and the first magnet device 2914 magnetically attach to each other, thus allowing the catheter 3200a to align with and attach to the implanted body member.
The illustrated embodiment shows the first magnetic tip 3214a having a positive pole on its outer surface and the first magnetic device 2914 having a negative pole on its top surface. In certain other embodiments, the first magnetic tip 3214a has a negative pole on its outer surface and the first magnetic device 2914 has a positive pole on its top surface such that the magnetic tip 3214a and the first magnetic device 2914 produce a mutually attractive force.
In certain other embodiments, a second catheter 3200b is also inserted into the patient and guided to the annuloplasty implant area. The poles of the magnetic tip 3214b and the second magnetic device 2916 are of opposite polarities such that the magnetic tip 3214b and the first magnetic device 2916 produce a mutually attractive force. In certain embodiments, the magnetic tip 3214b and the second magnet device 2914 magnetically attach to each other. Thus, both catheters 3200a and 3200b can be aligned with and attached to the implanted annuloplasty ring.
The illustrated embodiment shows the second magnetic tip 3214b having a negative pole on its outer surface and the second magnetic device 2916 having a positive pole on its top surface. In certain other embodiments, the second magnetic tip 3214b has a positive pole on its outer surface and the second magnetic device 2916 has a negative pole on its top surface such that the magnetic tip 3214b and the second magnetic device 2916 produce a mutually attractive force.
After the magnetic tip 3214a magnetically attaches to the magnetic device 2914, as shown in
In certain embodiments, thermal energy may be delivered. In the embodiment illustrated in
In embodiments where catheter 3200 activates an implant by sending activation energy to a magnetic device of the implant, energy may be delivered to either one or several magnetic devices simultaneously. In embodiments where the implant is composed of a plurality of shape memory segments, the catheter 3200 may activate the implant by sending activation energy to one or several shape memory segments simultaneously.
In certain other embodiments, after the first and second catheters 3200a, 3200b are magnetically attached to the first and the second magnetic devices 2914, 2916, respectively, a first pointer 3410 can be inserted through the catheter 3200a, and a second pointer 3410 can be inserted through the catheter 3200b. The first pointer 3410 contacts the heating wire 3110 at the first magnetic device 2914, and the second pointer 3420 contacts the heating wire 3110 at the second magnetic device 2916. In certain embodiments, a current passing from the first pointer 3410 to the second pointer 3410 can provide a circuit through the heating wire 3110, which causes the heating wire 3110 to generate heat. Thus, the heating wire 3110 transfers thermal energy to the shape memory tube 2012, which causes the annuloplasty ring to alter its shape.
In certain embodiments, an electric current may pass through the catheter 2900 which heats the end portion 3280 of the flexible tip 3212. In certain embodiments, the electric current may heat the magnetic tip 3214. The catheter 3200 may thus be used to apply energy to an implant as described above, such as implants 2000, 2900 and 2902 comprising magnetic devices described above.
In certain embodiments of the catheter 3200, media, such as a fluid like water or saline, can be injected through the catheter port 3260 and through the body portion 3210 to the distal portion's flexible tip 3212. The media may or may not be heated. Preferably, the media is heated to a threshold or target temperature before being delivered to the distal portion 3208. The media can flow through the a port 3260 of the catheter and heat the flexible tip portion 3212 of the catheter 3200. For example, the flexible tip portion 3212 may contain a balloon member (not illustrated) that is inflated by the media and heated as the heated media fills the distal portion 3208. The heat from the distal portion 3208 can be transferred to the body member 2000, preferably being transferred at least until the body member 2000 is activated, thereby changing the shape of the implantable device 2900.
After the body member 2000 has been activated, the catheter 3200 can be retracted or moved proximally relative to the guide sheath. As the catheter system 3200 is pulled proximally through the guide sheath, the distal portion is straightened and slid through the opening and into the guide sheath. The catheter 3200 and the guide sheath can be withdrawn from the vasculature, preferably withdrawn without damaging the vasculature tissue.
Annuloplasty Implants Adjusted Using Electromagnetic Induction Heating
In certain embodiments, an implant, such as an annuloplasty ring, may comprise a hysteretic material. In certain embodiments, an annuloplasty ring may be coated with an energy absorbing material that is hysteretic. In certain embodiments, a shape memory material may be processed via alloying to include energy absorbing materials, thereby eliminating the need for coating. In certain embodiments, a hysteretic material may partially cover an annuloplasty ring; for example, a wire comprising hysteretic material may wrap around the annuloplasty ring.
In certain embodiments, a hysteretic material is responsive to electromagnetic induction. Electromagnetic induction is the creation of a magnetic field due to the production of an electrical potential difference across a conductor situated in a changing magnetic flux. Electromagnetic induction may be used to heat an object in a process known as induction heating. In certain embodiments, electromagnetic induction may produce heat due to the magnetic field producing electric currents (eddy currents) in the hysteretic material, which causes resistive heating of the material.
In certain embodiments, electromagnetic induction may produce heat in a hysteretic material due to magnetic hysteresis. When the external magnetic field produced by electromagnetic induction is applied to a hysteretic material, such as a ferrite, the hysteretic material absorbs some of the external field in order to polarize the atoms of the hysteretic material. If the magnetic field is reversed, energy is absorbed from the magnetic field in order to reverse the polarity of the atoms, which, in the process of attempting to realign themselves to the new pole, generate molecular friction. The molecular friction is dissipated as heat. The dissipation of heat/energy is known as hysteresis loss.
In certain embodiments, hysteretic materials include crystalline and non-crystalline ferromagnetic materials, such as Co, Fe, FeOFe2O3, NiOFe2O3, CuOFe2O3, MgOFe2O3, MnBi, Ni, MnSb, MnOFe2O3, Y3Fe5O12, CrO2, MnAs, Gd, Dy, and EuO, as well as ferromagnetic alloys, such as Heusler alloys, in addition to those ferromagnetic materials described above. In certain embodiments, hysteretic materials for activation energy may include nanoshells, nanospheres and the like, particularly where radio frequency energy is used to energize the material, where such nanoparticles may be made from hysteretic materials.
In certain embodiments, the hysteretic coating may have a thickness between about 10 microns to about 1 centimeter. In certain embodiments, the hysteretic material coating the body member may have a thickness between about 5 microns to about 2 centimeters. In certain embodiments, the hysteretic material coating the body member may have a thickness between about 1 micron to about 10 centimeters.
In certain embodiments, the nitinol support structure may be a wire, a tube, or a C-shaped device in cross-section. In certain embodiments, the hysteretic coating may be external. In certain embodiments, the hysteretic coating may be internal. In certain embodiments, the hysteretic coating may be a planar layer adjacent to and touching the nitinol support structure. In certain embodiments, the implant may comprise an insulating layer. In certain embodiments, the implant may be a slip layer. In certain embodiments, the implant may comprise both an insulating layer and a slip layer.
In certain embodiments, the hysteretic coating has a Curie temperature (or Curie point) TC between approximately 42 degrees Celsius to 80 degrees Celsius. In certain embodiments, the TC of the hysteretic coating is between approximately 30 degrees Celsius to 100 degrees Celsius. In certain embodiments, the TC of the hysteretic coating is between approximately 15 degrees Celsius to 120 degrees Celsius.
In certain embodiments, the hysteretic coating has a magnetic permeability μ between approximately 50 μN/A2 and approximately 200,000 μN/A2. In certain embodiments, the μ of the hysteretic coating is between approximately 125 μN/A2 and approximately 25,000 μN/A2. In certain embodiments, the μ of the hysteretic coating is between approximately 875 μN/A2 and approximately 5,000 μN/A2.
In certain embodiments, a hysteretic material may respond a radio frequency in the range of approximately 1 kHz to 200 MHz. For example, a radio frequency signal sent at 30 MHz may cause a hysteretic material to heat up due to electromagnetic induction. In certain embodiments, a hysteretic material may respond a radio frequency in the range of approximately 3 Hz to 300 GHz. In certain embodiments, a hysteretic material may respond a radio frequency in the range of approximately 30 Hz to 30 MHz.
For example, a hysteretic coating may be exposed to magnetic fields of 400 Hz at 750 Gauss and 64,000 amperes per meter in order to cause thermal heating of a shape memory material within the coating. Heating may be accelerated by using a magnetic field of 1130 Gauss and 88,000 amperes per meter.
In certain embodiments, the activation frequency of the hysteretic material may be kept above 20 kHz so that the magnet may not be heard by human beings. In certain embodiments, the hysteretic material may be kept above 10 kHz. Higher activation frequencies may be configured to avoid heating of a patient's skin.
In certain embodiments, hysteretic materials may be activated at different energy levels. For example, in certain embodiments, a hysteretic material may expand at a first energy level and contract at a second energy level. In certain embodiments, a hysteretic material may be configured to respond to different frequencies. For example, a hysteretic material may heat and consequently expand at a certain frequency of electromagnetic radiation. On the other hand, the hysteretic material may not respond at other electromagnetic radiation frequencies. In certain embodiments, a hysteretic material may be configured to respond to different activation temperatures. For example, in certain embodiments, a hysteretic material may expand at a first temperature and contract at a second temperature.
In certain embodiments, a hysteretic coating may comprise two or more sections or zones of hysteretic material having different frequency response curves. The response zones may be configured in order to achieve a desired configuration of the coated implant as a whole when in a contracted state, either fully contracted or partially contracted. In certain embodiments, a hysteretic material may be selectively tuned to respond to a particular frequency of electromagnetic radiation. By only responding to selected frequencies, an implant may be activated without significantly impacting the image quality of a monitoring device.
In certain embodiments, a coating comprising hysteretic material may be applied using coating techniques well known in the art, such as thin film deposition, spraying, sputtering, reactive sputtering, metal ion implantation, physical vapor deposition, and chemical deposition in order to cover at least a portion of an annuloplasty ring. Such coatings can be either solid or microporous. When RF energy is used, for example, a microporous structure traps and directs the RF energy toward the shape memory material.
In certain embodiments, a hysteretic coating may further comprise a coating material selected from various groups of biocompatible organic or non-organic, metallic or non-metallic materials, as discussed above. In certain embodiments, a coating material may be selected from various groups of non-biocompatible materials.
In certain embodiments, the hysteretic material may be activated by exposure to an alternating current field. In certain embodiments, the hysteretic material may be activated by exposure to a rotating electromagnetic field. In certain embodiments, electromagnetic hysteresis heating may take place anytime a change in a magnetic field causes motion in a hysteretic material's hysteresis loop. For example, a spinning permanent magnet may cause hysteresis heating of a hysteretic material. In certain embodiments, the implant may be activated by exposure to low frequency fields, modulated fields, or spatially modulated magnetic fields. In certain embodiments, the hysteretic material may be heated by moving field lines out of a particle. In certain embodiments, exposure of a hysteretic material to a DC magnetic field may apply a torque to the material.
In certain embodiments, a low frequency field, such as a field with a strength of 1 Hz or less, may be modulated in a variety of ways to provide hysteresis heating since the inductance of the electromagnet may be very low. In certain embodiments, a hysteretic material may be heated by deflecting a low frequency field with a high frequency electromagnet. For example, the top pole (or top and bottom pole) of a C magnet may be exposed to a driving field to push the field lines back and forth. If both poles were driven, they may be driven either in phase of out of phase so as to create a push-pull or a Z-fold motion. More complex motions of the field may be generated depending on the shape and locations of the deflection coils or fields. These deflection fields may also be generated by permanent magnets. In certain embodiments, it may also be possible to raster scan the field, or make any arbitrary shape using vector deflection. Another method may be to constrict or spread out the magnetic field lines. For example, in certain embodiments, this may be done with deflection electromagnets as well.
In certain embodiments, a hysteretic material may be heated by mechanically scanned the material using a low frequency magnet structure, such as by using a resonant mechanical structure that can be made and excited to vary the flux lines. For example, a mumetal device would conduct the field lines through the device and allow for mechanical deflection of the field lines.
In order to transform the shape memory wire 3502, the wire 3502 may be heated to an activation temperature by a thermal energy transfer from the hysteretic coating 3504. The hysteretic coating 3504 may be heated by electromagnetic induction heating, as described above. For example, if the implant 3500 is within the body of a patient, then an external device generating a rapidly oscillating magnetic field directed at the implant 3500 may cause power from the magnetic field to be converted to heat in the coating 3504 of the implant 3500 due to magnetic hysteresis. The heat from the hysteretic coating 3504 may then be the transfer source of thermal energy for the shape memory wire 3502.
The implant 3600 may be divided into sections, including a curved or arcuate center section 3602, a first end 3606 and a second end 3604. In certain embodiments, the implant 3600 may have curvature out of the primary plane, for example, toward or away from the viewer. In certain embodiments, one or both ends 3604 and 3606 may be curved out of the primary plane.
Upon activation, the second end 3804 has returned to its austenite state, thereby undergoing deflection or deformation, while the first end 3802 remains unchanged. In certain embodiments, the first end may remain unchanged because it does not comprise a shape memory material. In certain embodiments, the first end may remain unchanged because it has a different transition temperature. In certain embodiments, the first end may remain unchanged because it configured to not deflect at austenitic temperatures.
Another embodiment of an adjustable ring and/or adjustable element 4000 is illustrated in
A portion of the insulating layer 4330 remains exposed in the illustrated embodiment. In some embodiments, the insulating layer 4330 also serves another function, for example, as a HIFU absorbing material, a MRI absorbing material, a lubricating layer, a drug eluting layer, a biodegradable layer, a porous layer, and combinations thereof.
In certain embodiments, the energy source is applied surgically to the hysteretic material either during implantation or at a later time. For example, the hysteretic material can be heated during implantation of the annuloplasty ring by generating a rapidly oscillating magnetic field near the material. As another example, the energy source can be surgically applied after the annuloplasty ring has been implanted by percutaneously inserting a catheter into the patient's body and applying the energy through the catheter. For example, RF energy can be transferred to the shape memory material through a catheter positioned on or near the hysteretic material. In certain embodiments, an internal activation catheter may be in direct contact with the implant when activating the hysteretic material. In certain embodiments, an internal activation catheter may be in close proximity to, but not touching, the implant. In certain embodiments, a catheter may serve as an antenna for electromagnetic energies such as microwave energy, radio frequency energy, or the like, or as a direct source of inductive heating.
In certain embodiments, the hysteretic material may be activated externally, such as external to the body of a patient which contains the material. In certain embodiments, external activation may be achieved using a wrappable inductive activation device. An embodiment of a wrappable inductive activation device 4400 is illustrated in
The electrical current in the coil(s) 4430 may be controlled using any suitable controller (not illustrated). In some preferred embodiments, the current control is automated, for example, using a computer, microprocessor, data processing unit, and the like. As discussed above, in some embodiments, the graft implant is dynamically remodeled, that is, the graft implant contemporaneously imaged and adjusted. In some embodiments, the controller is integrated with a system for imaging at least an adjustable element in the graft implant. As discussed above, in some embodiments, an adjustable element is adjusted in steps. Dynamic remodeling permits a user to monitor the effectiveness of each adjustment step.
In certain embodiments, external electromagnetic energy activation may surround the body of a patient using a technique similar to that used with fluoroscopic imaging equipment. In certain embodiments, external electromagnetic energy activation may be surround the body of a patient using a C-Arm type device that may be rotated and adjusted around the body of a patient.
While certain aspects and embodiments of the invention have been described, these have been presented by way of example only, and are not intended to limit the scope of the invention. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms without departing from the spirit thereof. The accompanying claims and their equivalents are intended to cover such forms or modifications as would fall within the scope and spirit of the invention.
This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application No. 60/750,974, filed Dec. 16, 2005; this application is also a continuation-in-part of U.S. patent application Ser. No. 11/124,364, filed May 6, 2005, which claimed priority to both U.S. provisional application Ser. No. 60/684,432, filed Jun. 29, 2004, and to U.S. patent application Ser. No. 11/181,686, filed Jul. 14, 2005, which claimed priority to U.S. Provisional Application No. 60/588,253, filed Jul. 15, 2004; this application is also a continuation-in-part of U.S. patent application Ser. No. 11/124,409, filed May 6, 2005, which claimed priority to both U.S. patent application Ser. No. 11/181,686, filed Jul. 14, 2005, which claimed priority to U.S. Provisional Application No. 60/588,253, filed Jul. 15, 2004, and to U.S. Provisional Application No. 60/684,432, filed Jun. 29, 2004; this application is also a continuation-in-part of U.S. patent application Ser. No. 11/600,470, filed Nov. 16, 2006, which claimed priority to U.S. Provisional Application No. 60/737,104, filed Nov. 16, 2005. The entirety of each of these applications is incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
60750974 | Dec 2005 | US | |
60584432 | Jun 2004 | US | |
60737104 | Nov 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11124364 | May 2005 | US |
Child | 11638501 | Dec 2006 | US |
Parent | 11124409 | May 2005 | US |
Child | 11638501 | Dec 2006 | US |
Parent | 11600470 | Nov 2006 | US |
Child | 11638501 | Dec 2006 | US |